Search results
Results from the WOW.Com Content Network
The International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, a 2015 Swiss NGO of pharmaceutical companies and others, defined a contract research organization (CRO), specifically pertaining to clinical trials services as: [8]: 10 "A person or an organization (commercial, academic, or other) contracted by the sponsor to perform one or ...
VWR primarily serves the government, biotechnology, life science, education, electronics and pharmaceutical sectors. In 2010, the company maintained operations in 25 countries and processed approximately 50,000 order lines daily from a logistical network, which includes 25 strategically located distribution centers. [6]
In 2004, United Research China Shanghai was acquired, providing coverage of China's consumer health market. In 2005, acquired PharMetrics, a U.S. provider of patient-centric integrated claims data. In 2006, acquired the Life Sciences practice of Strategic Decisions Group, a portfolio strategy consultant to the life sciences industry.
2006: ICON acquired outcomes research and health economics specialist, Ovation Research Group [24] 2007: ICON acquired European staffing group, DOCS International [25] 2008: ICON acquired US phase I provider, Healthcare Discoveries and US bioanalytical lab, Prevalere Life Sciences [26] [27] 2009: ICON acquired Veeda Laboratories, a UK biomarker ...
In 2004, United Research China Shanghai was acquired, providing coverage of China's consumer health market. In 2005, acquired PharMetrics, a U.S. provider of patient-centric integrated claims data. In 2006, acquired the Life Sciences practice of Strategic Decisions Group, a portfolio strategy consultant to the life sciences industry.
The Inotiv brand had been launched in November 2019 for the company's contract research organization division. [4] In November 2021, Inotiv acquired Envigo. [5] Envigo was formed in September 2015 by the merger of Huntingdon Life Sciences, Harlan Laboratories and three subsidiaries - GFA, NDA Analytics and LSR Associates. [6]
By mid-2014, Accelerator, a biotech investment firm, had raised more than US$30 million from investors, including Eli Lilly and Company, Pfizer, and Johnson & Johnson, for initial funding to create biotechnology startups at the Alexandria Center for Life Science, which encompasses more than 700,000 square feet (65,000 m 2) on East 29th Street ...
It provides expertise to life sciences and pharma, healthcare services, consumer products, financial services, energy and environment, media and entertainment, technology, travel and transport, industrials, and retail. [2] The firm also has a strong private equity practice. [3]